Nsgene A/s

Gloriana Therapeutics Sarl

Gloriana Therapeutics, Inc.

Biogen Idec Ma Inc.

Jens Tornøe

Lars Ulrik Wahlberg

Philip Kusk

Lars U Wahlberg

Mette Grønborg

William P Sisk

The invention comprises an implantable cell device that includes a membrane defining and enclosing a chamber; a distance body within the chamber for reducing the diffusion distance for a biological active factor to or across the membrane; and a support scaffold within the chamber for increasing the cell support surface area per unit volume of the chamber for distributing cells.

Implantable cell device with supportive and radial diffusive scaffolding

The invention features an implantable cell device. The device includes a membrane defining and enclosing a chamber; a distance body, within the chamber, for reducing the diffusion distance for a biological active factor to or across the membrane; and a support scaffold, within the chamber, for increasing the cell support surface area per unit volume of the chamber for distributing cells.

The invention provides a device for Encapsulated Cell Therapy. The device includes an implantable capsule containing cells which secrete a biologically active compound for providing a biological function. The capsule has a semi permeable outer membrane for delivery of the compound e.g. at a site in the central nervous system or the spinal cord, e.g. in the brain of a patient. The capsule is connected to a tether which e.g. facilitates removal of the capsule from the patient. To facilitate insertion of the capsule into the patient, a stiffener may be attached to the tether to make the tether more rigid. The invention further provides a container for storing a cell therapy device and a method of locating the device in the body of a patient.

Implantable therapy system for treating a living being with an active factor

Growing community of inventors

Ballerup, Denmark

Jens Tornøe